Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

Clinical trial NCT05006573 · TERMINATED

Trial details

NCT number: NCT05006573
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-cystic Fibrosis Bronchiectasis

Start date: 2021-07-21
Primary completion: 2024-04-16
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.